We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EPSFF market cap is 119.97M. The company's latest EPS is SEK -0.2851 and P/E is -20.41.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 7M | 6.9M | 6.9M | 10.6M | 13.1M |
| Operating Income | -63.3M | -69.4M | -77M | -96.8M | -77.2M |
| Net Income | -63.9M | -69.3M | -77.3M | -94.8M | -76M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 185.4M | 270.6M | 197.2M | 104.3M | 97.8M |
| Total Liabilities | 15.9M | 17.8M | 19.5M | 19.8M | 14M |
| Total Equity | 169.5M | 252.8M | 177.7M | 84.5M | 83.8M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -54.1M | -59.7M | -69.5M | -84.8M | -71.4M |
| Investing | -5.1M | -6.5M | -11.2M | -9.5M | -7.6M |
| Financing | 188.8M | 149.2M | -1.9M | -3M | 71.6M |
| Market Cap | 119.97M |
| Price to Earnings Ratio | -20.41 |
| Price to Sales Ratio | 118.53 |
| Price to Cash Ratio | 30.73 |
| Price to Book Ratio | 18.52 |
| Dividend Yield | - |
| Shares Outstanding | 266.59M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.45 |
| 52 Week Low | 0.45 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Episurf Medical AB (GM) |
| Address |
karlavagen 60 stockholm 115 42 |
| Website | https://www.episurf.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
